Stanford University
Showing 5,421-5,440 of 34,968 Results
-
HyeRan Choo
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. HyeRan Choo is a Clinical Associate Professor and Section Chief of Craniofacial Airway Orthodontics in the Department of Surgery, Division of Plastic and Reconstructive Surgery at Stanford University School of Medicine. She also serves as the Director of the Stanford Orthodontic Airway Plate Treatment Program for Pierre Robin Sequence (SOAP for PRS) at Lucile Packard Children’s Hospital Stanford and is a faculty fellow at the Stanford Mussallem Center for Biodesign.
Dr. Choo earned her dental degrees from Seoul National University (combined Undergraduate and Graduate Dental Surgery program) and The University of Pennsylvania (Dental Medicine program). She completed her Post-graduate Orthodontic Residency and Master of Science degree at The University of Alabama in Birmingham. After a Craniofacial Fellowship at the National Institutes of Health / National Institute of Dental and Craniofacial Research, Dr. Choo served as Director of Craniofacial Orthodontics at The Children’s Hospital of Philadelphia / The University of Pennsylvania.
In 2012, Dr. Choo relocated to the San Francisco Bay Area, where she became a craniofacial orthodontic provider for Kaiser Permanente Medical Centers in Oakland and Santa Clara. She joined the Stanford University faculty in 2016 as a part-time craniofacial orthodontist and clinical instructor and transitioned to a full-time position in 2019 as a craniofacial airway orthodontist and clinical assistant professor.
Her clinical expertise includes surgical and non-surgical craniofacial and airway orthodontic treatments for neonates, infants, and children with craniofacial dysmorphism and/or orofacial dysfunctions. Dr. Choo's treatment philosophy centers on providing minimally invasive yet highly effective treatments, grounded in a deep understanding of craniofacial growth and function. Her SOAP for PRS program is the first in the nation to non-surgically treat neonates with PRS using OAP, which she fabricates based on her innovative method of analyzing maxillomandibular computed tomography. -
Monica Seungah Choo
Affiliate, IT Services
BioDr. Choo practices obstetrics and gynecology at Stanford Medicine Partners Pleasanton. She is bilingual in English and Korean and speaks conversational Spanish. Dr. Choo is committed to supporting women through every stage of life—from adolescence and pregnancy to menopause and beyond. She believes in building lasting relationships with her patients and providing compassionate, personalized care.
Outside of medicine, Dr. Choo enjoys traveling, watching Korean dramas, and singing karaoke with friends and family. -
Mehak Chopra
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioHer expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues – ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.
-
Danny Hung-Chieh Chou
Associate Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.
